Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis.
Schnitzer
S E
SE
Schmid
T
T
Zhou
J
J
Brüne
B
B
D017209:Apoptosis; D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D003035:Cobalt / Q000494:pharmacology; D051546:Cyclooxygenase 2 / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism*; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009578:Nitrobenzenes / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000235:genetics; D019311:Staurosporine / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D008565:Membrane Proteins; D009578:Nitrobenzenes; D034741:RNA, Small Interfering; D013449:Sulfonamides; C080955:N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; D003035:Cobalt; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; C018021:cobaltous chloride; D019311:Staurosporine